MedPath

山东绿叶制药有限公司

Ownership
-
Established
1994-06-08
Employees
-
Market Cap
-
Website
https://www.luye.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

63

NMPA:63

Drug Approvals

Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-Release Tablets

Product Name
羟考酮纳洛酮缓释片
Approval Number
国药准字H20244210
Approval Date
Jun 28, 2024
NMPA

Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-Release Tablets

Product Name
羟考酮纳洛酮缓释片
Approval Number
国药准字H20244209
Approval Date
Jun 28, 2024
NMPA

Diethylamine Salicylate

Product Name
水杨酸二乙胺
Approval Number
国药准字H20103053
Approval Date
Jan 9, 2024
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022018
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022016
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022014
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022013
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022015
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022017
Approval Date
Dec 12, 2023
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H37022019
Approval Date
Dec 12, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.